Maze Therapeutics (MAZE) Amortizatization of Intangibles (2025 - 2026)

Maze Therapeutics (MAZE) posted Amortizatization of Intangibles of $2000.0 for Q1 2026, down 99.12% sequentially from $227000.0 in Q4 2025.

Analysis

Maze Therapeutics (MAZE) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends

Maze Therapeutics has reported Amortizatization of Intangibles for 2 years, with the latest figure at $2000.0 in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	4.33 Mn
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	678,000.00
10	Maze Therapeutics	1.55 Bn	1.55 Bn	-	-7,000.00

Historic Data

Download Data